Telos Capital Management, Inc. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
Telos Capital Management, Inc. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$2,660,438
-0.8%
26,119
-1.7%
0.37%
+3.6%
Q2 2023$2,681,539
+6.6%
26,574
-2.8%
0.36%
+1.7%
Q1 2023$2,514,907
+2.1%
27,336
+0.7%
0.35%
-2.2%
Q4 2022$2,462,913
+32.6%
27,149
+11.1%
0.36%
+17.3%
Q3 2022$1,857,000
-5.4%
24,436
+5.3%
0.31%
+2.0%
Q2 2022$1,962,000
-0.6%
23,206
+3.2%
0.30%
+17.2%
Q1 2022$1,974,000
-0.7%
22,496
-1.0%
0.26%
+3.2%
Q4 2021$1,987,000
+7.9%
22,716
+0.9%
0.25%
-1.6%
Q3 2021$1,842,000
-13.4%
22,523
-3.4%
0.25%
-10.3%
Q2 2021$2,127,000
-49.7%
23,308
-52.9%
0.28%
-53.7%
Q1 2021$4,226,000
-8.7%
49,436
+0.9%
0.61%
-13.9%
Q4 2020$4,627,000
+11.6%
49,004
+2.8%
0.70%
-2.6%
Q3 2020$4,145,000
+1.5%
47,664
+2.0%
0.72%
-8.4%
Q2 2020$4,083,000
+10.3%
46,750
+4.1%
0.79%
-13.8%
Q1 2020$3,702,000
-11.8%
44,893
+1.3%
0.92%
-4.2%
Q4 2019$4,195,000
+18.7%
44,307
+9.0%
0.96%
-1.1%
Q3 2019$3,534,000
-2.6%
40,666
+2.4%
0.97%
-8.9%
Q2 2019$3,627,000
-4.1%
39,722
+1.0%
1.06%
-9.8%
Q1 2019$3,782,000
+13.6%
39,342
+1.4%
1.18%
-4.3%
Q4 2018$3,330,000
+2.7%
38,812
+3.1%
1.23%
+18.8%
Q3 2018$3,244,000
+15.7%
37,652
+1.4%
1.04%
+7.3%
Q2 2018$2,805,000
-4.5%
37,130
+2.2%
0.97%
-7.5%
Q1 2018$2,938,000
-2.9%
36,343
+0.8%
1.04%
-2.2%
Q4 2017$3,026,000
+1.6%
36,038
+3.9%
1.07%
-7.0%
Q3 2017$2,977,000
+4.3%
34,673
+1.4%
1.15%
+0.8%
Q2 2017$2,854,000
+20.4%
34,188
+7.2%
1.14%
+15.5%
Q1 2017$2,370,000
+11.4%
31,906
+9.3%
0.99%
+4.3%
Q4 2016$2,127,000
-1.8%
29,199
+6.5%
0.95%
-6.2%
Q3 2016$2,165,000
-0.2%
27,416
+4.3%
1.01%
-4.9%
Q2 2016$2,169,000
+21.1%
26,290
+6.3%
1.06%
+12.9%
Q1 2016$1,791,000
-2.1%
24,729
+16.3%
0.94%
-4.8%
Q4 2015$1,830,000
-4.9%
21,271
+1.6%
0.99%
-16.2%
Q3 2015$1,925,000
-29.4%
20,943
-24.5%
1.18%
-21.8%
Q2 2015$2,728,000
+2.8%
27,743
+3.1%
1.50%
-2.8%
Q1 2015$2,654,000
+2.7%
26,914
-3.5%
1.55%
-1.7%
Q4 2014$2,583,000
+4.3%
27,879
+6.0%
1.58%
+2.3%
Q3 2014$2,477,000
+6.8%
26,309
+2.7%
1.54%
+7.4%
Q2 2014$2,319,000
+9.8%
25,619
+3.1%
1.43%
-2.9%
Q1 2014$2,112,000
+0.7%
24,845
-4.8%
1.48%
-4.0%
Q4 2013$2,098,000
+2.7%
26,100
-2.0%
1.54%
-7.2%
Q3 2013$2,043,000
+8.4%
26,631
-0.1%
1.66%
+0.2%
Q2 2013$1,885,00026,6611.66%
Other shareholders
NOVARTIS A G shareholders Q4 2020
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders